In vitro prevention of the emergence of multidrug resistance in a pediatric rhabdomyosarcoma cell line

Clinical Cancer Research

Volumn 7, Issue 10, 2001, Pages 3193-3198

  Cocker, H A ^a   Tiffin, N ^a   Pritchard Jones, K ^a   Pinkerton, C R ^a   Kelland, L R ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BIRICODAR; CISPLATIN; DOXORUBICIN; ETOPOSIDE; GLYCOPROTEIN P; INDOMETACIN; MESSENGER RNA; MIDOSTAURIN; MULTIDRUG RESISTANCE MODULATOR; MULTIDRUG RESISTANCE PROTEIN; PROTEIN KINASE C INHIBITOR; PROTEIN P53; RAZOXANE; TARIQUIDAR; UNCLASSIFIED DRUG; VALSPODAR; VINCRISTINE;

ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CHILDHOOD CANCER; DOSE RESPONSE; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHABDOMYOSARCOMA; SARCOMA;

ANTINEOPLASTIC AGENTS; CHILD; CISPLATIN; CYCLOSPORINS; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INDOMETHACIN; INHIBITORY CONCENTRATION 50; P-GLYCOPROTEIN; PIPERIDINES; PYRIDINES; QUINOLINES; RAZOXANE; RHABDOMYOSARCOMA; RNA, NEOPLASM; STAUROSPORINE; TIME FACTORS; TUMOR CELLS, CULTURED; VINCRISTINE;

EID: 0034792174     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Immunohistochemical detection of P-glycoprotein-prognostic correlation in soft-tissue sarcoma of childhood
2. P-glycoprotein expression at diagnosis may not be a primary mechanism of therapeutic failure in childhood rhabdomyosarcoma
3. Characterization and modulation of drug resistance of human paediatric rhabdomyosarcoma cell lines
4. Induction of multiple-drug resistance during anti-neoplastic chemotherapy in vitro
5. A single 24h contact time with adriamycin provokes the emergence of resistant cells expressing the Gp 170 protein
6. Cancer research 2000: Drug resistance, new targets and drugs in development
7. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs
8. Rapid up-regulation of mdr1 expression by anthracyclines in a classical multidrug-resistant cell line
9. Induction of MDR1 gene expression by anthracycline analogues in a human drug resistant leukaemia cell line
10. Rapid activation of MDR1 gene expression in human metastatic sarcoma after in vivo exposure to doxorubicin
11. In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC-833
12. Cellular and biochemical characterization of VX-710 as a chemosensitizer: Reversal of P-glycoprotein-mediated multidrug resistance in vitro
13. XR9576, a novel potent modulator of P-glycoprotein-mediated multidrug resistance
14. Benefit of cyclosporine (CsA) modulation of anthracycline resistance in high-risk AML: A Southwest Oncology Group (SWOG) study
15. Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP but not P-glycoprotein
16. Protein kinases and multidrug resistance
17. Inhibition of the growth of glioblastomas by CGP 41251, an inhibitor of protein kinase C, and by a phorbol ester tumor promoter
18. Dexrazoxane significantly impairs the induction of doxorubicin resistance in the human leukaemia cell line K562
19. Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein. Altered phenotype and resistance to cyclosporins
20. Resistance to the chemosensitizer verapamil in a multidrug-resistant (MDR) human multiple-myeloma cell line
21. Effects of a new antioestrogen, idoxifene, on cisplatin- and doxorubicin-sensitive and -resistant human ovarian carcinoma cell lines
22. A 190-kDa protein overexpressed in non-P-glycoprotein-containing multidrug- resistant cells and its relationship to the MRP gene
23. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays